About
Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 15 2026
BioCryst to Report First Quarter 2026 Financial Results on May 6
Apr 6 2026
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
Feb 26 2026
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
Feb 11 2026
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
Feb 5 2026
BioCryst to Report Fourth Quarter 2025 Financial Results on February 26
Financials
Revenue
$874.84 M
Market Cap
$2.26 B
P/E Ratio
7.45
EPS
1.21
Translate